Acetyl-Histone H3 (K123) Antibody

What is the biological significance of H3K123 acetylation?

Histone H3 lysine 123 (K123) acetylation plays a critical role in gene expression regulation, chromatin structure modification, and DNA repair processes. This specific acetylation mark is particularly important for transcriptional activation and is frequently associated with actively transcribed genes . Unlike histone tail modifications that have been extensively studied, H3K123 acetylation occurs in the globular domain of histone H3, representing a distinct class of histone modifications with unique functional implications for chromatin dynamics .

How does H3K123 acetylation differ from other histone H3 acetylation marks?

H3K123 acetylation differs from more commonly studied histone tail modifications such as H3K27ac in several important ways. While H3K27 acetylation occurs on the N-terminal tail that protrudes from the nucleosome core and is widely used to identify active enhancers, H3K123 acetylation occurs within the globular domain of histone H3 . Research indicates that globular domain acetylations like H3K123ac (along with H3K64ac and H3K122ac) can mark both active gene promoters and a subset of active enhancers, including some that lack the canonical H3K27ac mark . This suggests that H3K123ac may regulate gene expression through mechanisms distinct from tail modifications.

What experimental techniques can be used to study H3K123 acetylation?

Several techniques can be employed to study H3K123 acetylation, with Chromatin Immunoprecipitation (ChIP) being particularly valuable. Research protocols typically involve cross-linking cells with 1% formaldehyde, sonicating chromatin to approximately 100-200bp fragments, and then performing immunoprecipitation with specific anti-acetyl H3K123 antibodies . Western blotting with recommended dilutions of 1:500-1:2000 can be used to detect this modification in acid-extracted histones or whole cell extracts . For more detailed analyses, sequential ChIP (ChIP-reChIP) can be performed to identify genomic regions that simultaneously contain H3K123ac and other histone modifications . Immunofluorescence techniques can also visualize the nuclear distribution of this modification.

What are the critical specifications to consider when selecting an H3K123ac antibody?

When selecting an H3K123ac antibody for research, several specifications require careful consideration:

Most commercial H3K123ac antibodies are produced in rabbits and undergo affinity purification using epitope-specific immunogens . Verification of specificity through peptide array analysis or knockout controls is essential to ensure the antibody specifically recognizes acetylated K123 without cross-reactivity to other acetylation sites.

How can researchers validate the specificity of an Acetyl-Histone H3 (K123) antibody?

Validating antibody specificity is crucial for reliable experimental results. Researchers should:

• Perform peptide competition assays using acetylated and non-acetylated peptides spanning the K123 region to confirm binding specificity.

• Conduct dot blot analyses with various modified histone peptides (similar to the approach shown for H3K23ac antibodies) .

• Compare immunoreactivity in samples treated with histone deacetylase inhibitors (like sodium butyrate) versus untreated controls to verify sensitivity to acetylation levels.

• Use genetic models with mutations at K123 (e.g., K123R) that prevent acetylation as negative controls.

• Employ sequential ChIP with antibodies against known co-occurring modifications to validate target specificity in chromatin contexts .

For Western blot validation, researchers should observe a single band at approximately 17 kDa corresponding to histone H3, with signal intensity increasing after treatments that enhance histone acetylation.

What are the optimal conditions for Western blotting with Acetyl-Histone H3 (K123) antibody?

For optimal Western blotting results with Acetyl-Histone H3 (K123) antibody:

• Extract histones using acid extraction methods (0.2N HCl or H2SO4) to efficiently isolate histones from nuclear proteins.

• Load 5-20 μg of acid-extracted histones or use whole cell extracts with appropriate controls.

• Use 15-18% SDS-PAGE gels to achieve adequate separation of the relatively small histone proteins.

• Transfer to PVDF membranes (preferred over nitrocellulose for histone applications) using standard transfer buffers.

• Block with 5% non-fat dry milk or BSA in TBST.

• Apply primary antibody at dilutions between 1:500-1:2000 as recommended by manufacturers .

• Incubate overnight at 4°C for optimal binding.

• Use appropriate HRP-conjugated secondary antibodies (typically anti-rabbit IgG).

• Include positive controls such as extracts from cells treated with histone deacetylase inhibitors.

• Include loading controls with antibodies against total histone H3 or tubulin .

The expected molecular weight for the histone H3 band is approximately 17 kDa.

How should researchers design and execute ChIP experiments with Acetyl-Histone H3 (K123) antibody?

Chromatin immunoprecipitation with Acetyl-Histone H3 (K123) antibody requires careful planning and execution:

• Cell preparation and cross-linking:

  • Cross-link cells with 1% formaldehyde for 10 minutes at room temperature.

  • Quench with glycine (final concentration 0.125 M).

  • Wash cells in cold PBS and prepare nuclear extracts.

• Chromatin fragmentation:

  • Sonicate chromatin to achieve fragment sizes of 100-200 bp using a biorupter or similar device .

  • Verify fragmentation efficiency by agarose gel electrophoresis.

• Immunoprecipitation:

  • Pre-clear chromatin with protein A/G beads.

  • Incubate chromatin with 2-5 μg of Acetyl-Histone H3 (K123) antibody overnight at 4°C.

  • Add protein A/G beads and incubate for 2-4 hours.

  • Perform stringent washing steps to remove non-specific binding.

• Controls and validation:

  • Include IgG negative controls.

  • Use input chromatin (5-10%) as a reference.

  • Include positive controls targeting regions known to be enriched for H3K123ac.

  • For sequential ChIP experiments, elute primary ChIP material and perform second immunoprecipitation with antibodies against other modifications of interest .

• Analysis:

  • Process recovered DNA for qPCR, sequencing library preparation, or other downstream applications.

  • When analyzing results, normalize to input and compare enrichment to IgG controls.

  • For ChIP-seq data, compare H3K123ac profiles with other histone modifications like H3K27ac to identify unique regulatory elements.

What are the key considerations for immunofluorescence using Acetyl-Histone H3 (K123) antibody?

When performing immunofluorescence with Acetyl-Histone H3 (K123) antibody, researchers should consider:

• Fixation method: Paraformaldehyde (4%) for 10-15 minutes is typically effective for preserving histone modifications.

• Permeabilization: Use 0.2-0.5% Triton X-100 to ensure antibody access to nuclear epitopes.

• Antigen retrieval: Citrate buffer (pH 6.0) heat treatment may improve epitope accessibility.

• Blocking: Use 5% BSA or normal serum (from the species of secondary antibody) to reduce background.

• Primary antibody dilution: Start with 1:200-1:500 dilutions and optimize as needed.

• Incubation time and temperature: Overnight at 4°C typically yields best results.

• Controls: Include samples treated with histone deacetylase inhibitors as positive controls and peptide competition controls to confirm specificity.

• Counterstaining: DAPI for nuclear visualization helps to interpret the nuclear distribution pattern of H3K123ac.

• Confocal microscopy: Recommended for precise localization within nuclear structures.

Expected results include nuclear staining with potential enrichment in euchromatic regions associated with active transcription.

How can researchers integrate H3K123ac ChIP-seq data with other epigenetic profiles?

Integrating H3K123ac ChIP-seq data with other epigenetic profiles requires sophisticated bioinformatic approaches:

• Data preprocessing and quality control:

  • Process raw ChIP-seq data through standard pipelines (adapter trimming, quality filtering, alignment to reference genome).

  • Generate normalized coverage tracks and peak calls using tools like MACS2.

  • Perform quality metrics assessment (FRiP, IDR, etc.).

• Integrative analysis strategies:

  • Compare H3K123ac peaks with H3K27ac, H3K4me3, and other histone modifications to identify unique and overlapping regulatory elements.

  • Pay particular attention to regions with H3K122ac/H3K123ac but lacking H3K27ac, as these may represent a novel class of regulatory elements .

  • Use tools like deepTools, ChromHMM, or similar algorithms to identify combinatorial patterns of histone modifications.

• Functional annotation:

  • Correlate histone modification patterns with gene expression data (RNA-seq).

  • Perform pathway enrichment analysis on genes associated with different chromatin states.

  • Use tools like GREAT for genomic region functional annotation.

• Visualization and interpretation:

  • Create heatmaps centered on transcription start sites, gene bodies, or enhancer regions.

  • Generate aggregate plots to visualize average modification profiles across genomic features.

  • Use genome browsers (UCSC, IGV) to examine specific loci of interest.

This integrative approach can reveal unique functions of H3K123ac in gene regulation distinct from more commonly studied modifications like H3K27ac, particularly in identifying novel enhancer elements .

What are the implications of H3K123 acetylation in cancer and disease research?

H3K123 acetylation has emerging implications for cancer and disease research that warrant investigation:

• Cancer epigenetics: Altered histone acetylation patterns, including H3K123ac, may contribute to oncogene activation and tumor suppressor silencing. Research suggests that globular domain acetylations could play distinct roles in cancer development compared to tail modifications.

• Therapeutic targeting: Histone deacetylase (HDAC) inhibitors are employed as cancer therapeutics, but their effects on globular domain acetylations like H3K123ac are less understood than their impact on tail acetylations. Studying H3K123ac changes in response to HDAC inhibitors could reveal novel mechanisms of action and resistance.

• Biomarker potential: Patterns of H3K123ac occupancy might serve as biomarkers for cancer progression or therapeutic response. Researchers should analyze H3K123ac profiles across cancer subtypes and correlate with clinical outcomes.

• Developmental disorders: Given the role of histone acetylation in development, dysregulation of H3K123ac might contribute to developmental disorders. Researchers can study H3K123ac patterns during differentiation and in disease models.

• Interaction with mutant histones: Research has shown that certain histone H3 mutations affect protein stability . Investigating how these mutations impact H3K123ac levels could provide insights into disease mechanisms involving chromatin dysregulation.

Study designs should include comprehensive profiling of H3K123ac in normal versus disease tissues, correlation with gene expression, and functional validation through site-specific mutation of K123 (e.g., K123R to prevent acetylation).

How does H3K123ac interact with other histone modifications and chromatin remodeling complexes?

The interaction of H3K123ac with other histone modifications and chromatin remodeling complexes represents a complex regulatory network:

• Histone modification crosstalk:

  • H3K123ac may function cooperatively with other activating marks like H3K4me3 at promoters.

  • Sequential ChIP experiments can determine co-occurrence of H3K123ac with other modifications on the same nucleosomes .

  • Researchers should investigate potential antagonistic relationships with repressive marks like H3K27me3.

• Writer and eraser enzymes:

  • Identify the specific histone acetyltransferases (HATs) responsible for depositing H3K123ac.

  • Determine which histone deacetylases (HDACs) remove this modification.

  • Test the effects of HAT/HDAC inhibitors specifically on H3K123ac levels.

• Reader proteins and effector complexes:

  • Perform protein interaction studies (co-IP, mass spectrometry) to identify proteins that specifically bind H3K123ac.

  • Investigate whether H3K123ac facilitates recruitment of specific transcription factors or chromatin remodeling complexes.

  • Use techniques like CRISPR-Cas9 to delete potential enhancers marked by H3K123ac to validate their functional importance .

• Nucleosome stability and chromatin accessibility:

  • Assess how H3K123ac affects nucleosome stability, as globular domain acetylations can directly impact histone-DNA interactions.

  • Combine H3K123ac ChIP-seq with ATAC-seq or DNase-seq to correlate this modification with chromatin accessibility.

  • Investigate whether H3K123ac changes precede or follow chromatin opening during gene activation.

Understanding these interactions will provide deeper insights into the unique roles of globular domain acetylations in chromatin regulation beyond what is known about tail modifications.

What are common technical challenges with Acetyl-Histone H3 (K123) antibody and how can they be addressed?

Researchers frequently encounter several technical challenges when working with Acetyl-Histone H3 (K123) antibody:

• Low signal intensity in Western blots:

  • Ensure proper histone extraction using acid extraction methods

  • Increase antibody concentration or incubation time

  • Use enhanced chemiluminescence detection systems

  • Treat cells with HDAC inhibitors to increase acetylation levels as a positive control

• High background in immunostaining:

  • Optimize blocking conditions (test BSA vs. serum)

  • Increase washing duration and detergent concentration

  • Pre-absorb antibody with unrelated proteins

  • Reduce primary antibody concentration

• Poor ChIP efficiency:

  • Optimize chromatin fragmentation (aim for 100-200bp fragments)

  • Increase antibody amount (typically 2-5μg per ChIP)

  • Extend antibody incubation time

  • Validate antibody specificity with peptide competition assays

• Cross-reactivity with other acetylation sites:

  • Perform dot blot analyses with various modified peptides

  • Use peptide competition in Western blots and ChIP

  • Consider alternative antibody clones if persistent cross-reactivity occurs

• Batch-to-batch variability:

  • Maintain consistent lot numbers for critical experiments

  • Revalidate new antibody lots before use

  • Include internal standards across experiments

Methodical optimization of these parameters and inclusion of appropriate controls will significantly improve experimental outcomes with Acetyl-Histone H3 (K123) antibody.

How can researchers quantitatively analyze H3K123ac levels across different experimental conditions?

Quantitative analysis of H3K123ac levels requires rigorous experimental design and analytical approaches:

• Western blot quantification:

  • Use digital imaging systems rather than film exposure

  • Ensure signal is within linear range of detection

  • Normalize H3K123ac signal to total H3 signal from the same samples

  • Apply appropriate statistical analysis to biological replicates (minimum n=3)

• ChIP-qPCR analysis:

  • Calculate percent input or fold enrichment over IgG control

  • Include multiple primer sets for regions of interest

  • Use positive control regions (known acetylated regions) and negative control regions

  • Apply normalization to account for IP efficiency variations

• ChIP-seq quantitative analysis:

  • Use spike-in controls (e.g., Drosophila chromatin) for between-sample normalization

  • Calculate normalized read counts within peaks

  • Apply differential binding analysis tools (DiffBind, MACS2 bdgdiff)

  • Generate metaplots and heatmaps to visualize distribution patterns

• Mass spectrometry approaches:

  • Use stable isotope labeling techniques (SILAC) to compare acetylation levels

  • Employ multiple reaction monitoring for targeted quantification

  • Include synthetic acetylated peptide standards

  • Account for digestion efficiency and ionization differences

• Immunofluorescence quantification:

  • Use automated image analysis software for unbiased quantification

  • Measure nuclear intensity relative to DAPI or total H3 staining

  • Analyze multiple cells (>100) across different fields

  • Apply appropriate statistical tests for significance

These quantitative approaches enable robust comparison of H3K123ac levels across different experimental conditions, cell types, or disease states.

What emerging technologies might advance the study of H3K123ac dynamics and function?

Several emerging technologies hold promise for advancing our understanding of H3K123ac:

• Single-cell epigenomics:

  • Single-cell ChIP-seq adaptations could reveal cell-to-cell variability in H3K123ac patterns

  • CUT&Tag and CUT&RUN methods offer improved sensitivity for limited samples

  • Single-cell multi-omics approaches can correlate H3K123ac with transcription at single-cell resolution

• Live-cell imaging of histone modifications:

  • Development of acetylation-specific intrabodies or nanobodies

  • FRET-based sensors for real-time monitoring of acetylation dynamics

  • Photoactivatable histone modification probes

• CRISPR-based epigenome editing:

  • dCas9 fused to histone acetyltransferases for site-specific H3K123ac deposition

  • CRISPR screens targeting writer/eraser enzymes affecting H3K123ac

  • Precise deletion of regulatory elements marked by H3K123ac to assess functional impact

• Structural biology approaches:

  • Cryo-EM studies of nucleosomes with H3K123ac to understand structural implications

  • Hydrogen-deuterium exchange mass spectrometry to probe conformational changes

  • Molecular dynamics simulations to predict functional consequences

• Proteomics innovations:

  • Proximity labeling techniques to identify proteins interacting with H3K123ac regions

  • Crosslinking mass spectrometry to map protein-protein interactions around H3K123ac

  • Development of reader domain-specific affinity reagents

These technological advances will enable researchers to move beyond correlative observations to causative understanding of H3K123ac function in gene regulation.

What are the most significant unanswered questions regarding H3K123 acetylation in gene regulation?

Despite progress in histone acetylation research, several key questions about H3K123 acetylation remain unanswered:

• Enzymatic regulation:

  • Which specific histone acetyltransferases catalyze H3K123 acetylation?

  • Which histone deacetylases remove this modification?

  • How is the activity of these enzymes regulated in different cellular contexts?

• Functional specificity:

  • Does H3K123ac serve functions distinct from other globular domain acetylations like H3K64ac and H3K122ac?

  • What determines whether H3K123ac marks promoters versus enhancers?

  • Why do some enhancers show H3K123ac but lack the canonical H3K27ac mark?

• Mechanistic impact:

  • How does H3K123ac physically alter nucleosome structure and stability?

  • Does H3K123ac directly affect DNA accessibility or transcription factor binding?

  • What are the kinetics of H3K123ac deposition and removal during transcriptional activation?

• Developmental dynamics:

  • How does the H3K123ac landscape change during cellular differentiation?

  • Is H3K123ac involved in establishing or maintaining cell identity?

  • What is the inheritance pattern of H3K123ac through cell division?

• Disease relevance:

  • Are there specific diseases associated with aberrant H3K123ac patterns?

  • Could targeting H3K123ac or its regulatory enzymes offer therapeutic opportunities?

  • How do environmental factors influence H3K123ac levels?

Addressing these questions will require integrated approaches combining genomics, biochemistry, structural biology, and functional genetics to fully elucidate the role of H3K123 acetylation in chromatin regulation.